Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00930280 · ClinicalTrials.gov registry record

Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III

A clinical trial of Stroke, sponsored by University of Cincinnati.

Active
Registry status
1,260
Enrollment target
1
Study location

NCT00930280 is a study of Stroke that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 1,260 participants, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00930280, a study of Stroke, is active but no longer recruiting, sponsored by University of Cincinnati.

ACTIVE NOT RECRUITING
Registry status
1,260 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH). ICH, a type of bleeding into brain tissue, is a type of stroke that can result in death or disability in a large number of people. Our study hopes to identify a specific genetic risk factor that will help identify at risk individuals and target treatment strategies.

Conditions Studied

Stroke

Study Locations (1)

Ohio

  • University of Cincinnati Department of Neurology - Cincinnati

Trial Details

FieldValue
Enrollment Target 1,260 participants
Start Date 2008-07
Est. Completion 2025-06

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00930280

The ClinicalTrials.gov registry entry for NCT00930280 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (90% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00930280 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00930280 about?

NCT00930280 is a clinical study titled "Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III". The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH). ICH, a type of bleeding into brain tissue, is a type of stroke that can result in death or disability in a large number of people. Our study hopes to identify a specific genetic ris...

What is the current status of trial NCT00930280?

This trial is currently active not recruiting. The enrollment target is 1,260 participants. The study started on 2008-07. Estimated completion is 2025-06.

What conditions does trial NCT00930280 study?

This clinical trial studies the following conditions: Stroke.

Who is sponsoring clinical trial NCT00930280?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00930280 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.